Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Moses

Showing results (541-550 of 704) with videos related to

Pageof 71
Sort By:
The Journal of Urology|October 20, 2020
Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate CancerMark C Xu, Heather L Huelster, Jeremy B Hatcher, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2023
Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfactionFrank A Schumacher, Irene B Helenowski, Zequn Sun, et al.
Prostate Cancer|January 7, 2026
Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-TNeal D Shore, Emmanuel S Antonarakis, Jason Hafron, et al.
The Journal of Urology|August 30, 2014
Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasiaTristan M Nicholson, Michael A Moses, Kristen S Uchtmann, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|December 19, 2015
The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder CancerZachary Klaassen, John M DiBianco, Rita P Jen, et al.
British Journal of Pharmacology|May 20, 2015
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesisNicole A Hofmann, Jiang Yang, Sunia A Trauger, et al.
Bioorganic & Medicinal Chemistry|March 1, 2011
Development of sulfonamide AKT PH domain inhibitorsAli Md Ahad, Song Zuohe, Lei Du-Cuny, et al.
BMC Cancer|April 18, 2015
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancerAndrej Jedinak, Adam Curatolo, David Zurakowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Lipocalin 2 promotes breast cancer progressionJiang Yang, Diane R Bielenberg, Scott J Rodig, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
The influence of T cell cross-reactivity on HCV-peptide specific human T cell responsePatrick T F Kennedy, Simonetta Urbani, Rebecca A Moses, et al.
Pageof 71

Showing results (541-550 of 704) with videos related to

Sort By:
Pageof 71
The Journal of Urology|October 20, 2020
Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate CancerMark C Xu, Heather L Huelster, Jeremy B Hatcher, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2023
Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfactionFrank A Schumacher, Irene B Helenowski, Zequn Sun, et al.
Prostate Cancer|January 7, 2026
Cellular Immunotherapy for Prostate Cancer: Lessons Learned From 15 Years of Sipuleucel-TNeal D Shore, Emmanuel S Antonarakis, Jason Hafron, et al.
The Journal of Urology|August 30, 2014
Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasiaTristan M Nicholson, Michael A Moses, Kristen S Uchtmann, et al.
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|December 19, 2015
The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder CancerZachary Klaassen, John M DiBianco, Rita P Jen, et al.
British Journal of Pharmacology|May 20, 2015
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesisNicole A Hofmann, Jiang Yang, Sunia A Trauger, et al.
Bioorganic & Medicinal Chemistry|March 1, 2011
Development of sulfonamide AKT PH domain inhibitorsAli Md Ahad, Song Zuohe, Lei Du-Cuny, et al.
BMC Cancer|April 18, 2015
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancerAndrej Jedinak, Adam Curatolo, David Zurakowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Lipocalin 2 promotes breast cancer progressionJiang Yang, Diane R Bielenberg, Scott J Rodig, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
The influence of T cell cross-reactivity on HCV-peptide specific human T cell responsePatrick T F Kennedy, Simonetta Urbani, Rebecca A Moses, et al.
Pageof 71